Prossin, A R
Koch, A E
Campbell, P L
Barichello, T
Zalcman, S S
Zubieta, J-K
Article History
Received: 15 January 2015
Revised: 8 May 2015
Accepted: 16 June 2015
First Online: 18 August 2015
Competing interests
: AEK has recently been employed by Eli Lilly companies and has consulted for Metastatix, Pennside Partners, Cypress Bioscience, Takeda Pharmaceuticals, NiCox SA, Celtaxsys, Gerson Lehrman Group of Healthcare and Biomedical Advisors, Guidepoint Global, UCB Pharmaceuticals and the Fund for Autoimmune Research and has been an expert for Kirkland and Ellis. AEK has received investigator-initiated research grants for Bristol-Myers Squibb, Roche, and Takeda Pharmaceuticals. The remaining authors declare no conflict of interest.